Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Published:2023-01-31 Issue:3 Volume:41 Page:253-262
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Lin Chenyu¹,Galal Ahmed¹,Rizzieri David²,Chawla Sant³,Lee Seung T.⁴,Georgy Angela⁵,Dabovic Kristina⁵,Strack Thomas⁵,McKinney Matthew¹

Affiliation:

1. Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USA

2. Novant Health Cancer Institute, Charlotte, North Carolina, USA

3. Sarcoma Oncology Center, Santa Monica, California, USA

4. Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, USA

5. Molecular Templates, Inc, Austin, Texas, USA

Funder

Molecular Templates and the Duke Cancer Institute

NIH/NHLBI

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2022.2162073

Reference46 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

2. CD20: a regulator of cell-cycle progression of B lymphocytes

3. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

5. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Ethical Implications in Rural Community Mental Health: The Role of Mental Health Providers;Community Mental Health Journal;2023-06-14